The dosage effects of dexamethasone on osteogenic activity andbiocompatibility of poly(lactic-co-glycolic acid)/hydroxyapatite nanofibers

Abstract

Poly(lactic-co-glycolic acid) (PLGA) based biomaterials have many advantages and potential applications in bone tissue engineering. Whereas, a significant problem which could not be ignored was that the acidic by-products generated during its degradation induced severe inflammatory reactions and negatively regulated bone regeneration. In this research, feasibility of using dexamethasone (Dex) to improve the biocompatibility of PLGA is investigated in detail. Hereby, various contents of PLGA/hydroxyapatite (PH) nanofibers loaded with Dex were synthesized by electrospinning technique. It was shown that 0.5% (wt) Dex in PH scaffolds was the minimum content which was required for anti-inflammatory effect. Admittedly, Dex to some extent had cytotoxic effect on osteoblasts and an inhibitory effect on ALP activity in this study; nevertheless, the relatively low Dex (<2% [wt]) had no inhibitory effects on osteoblasts maturation and mineralization. By this token, Dex is a good candidate for improving biocompatibility of PLGA based biomaterials. Moreover, the cytotoxic effects of Dex should be concerned. This study will provide a rationale for optimizing biocompatibility of PLGA based biomaterials by using Dex.

Keywords:

• Electrospun nanofibers
• poly(lactic-co-glycolic acid)/hydroxyapatite
• dexamethasone
• biocompatibility

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This study was supported by the National Natural Science Foundation of China [81600823], and the Science Technology Program of Jilin Province [20170520009JH]. China Postdoctoral Science Foundation [2017M611332], and the National Key Research and Development Program of China [2016YFC1102803].